Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.45 EUR | -2.68% |
|
-6.29% | -8.59% |
06/06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
05/06 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
I-MAB | Other Pharmaceuticals | -2.68% | -6.29% | - | - | - | 13Cr | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- IMAB Stock
- 0VY Stock
- Charts I-Mab
- Comparison Chart